Menin inhibitors in the treatment of acute myeloid leukemia
Blood · 06.02.2025 · 145 (6) · 561-566
DOI: 10.1182/blood.2024026232 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood, erschienen am 06.02.2025. Verfasst von Gerwin Huls und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Proto-Oncogene Proteins, Antineoplastic Agents. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the (oligo)clonal expansion of myeloid progenitor cells. Despite advances in treatment, AML remains challenging to cure, particularly in patients with specific genetic abnormalities. Menin inhibitors have emerged as a promising therapeutic approach, targeting key genetic drivers of AML, such as KMT2A (lysine methyl transferase 2A) rearrangements and NPM1 mutations. Here, we review the clinical value of menin inhibitors, highlighting their mechanism of action, efficacy, safety, and potential to transform AML treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
ORCID-Profile: Carolien M Woolthuis, Jan Jacob Schuringa
Zitieren
APA
Huls, G., Woolthuis, C. M., & Schuringa, J. J. (2025). Menin inhibitors in the treatment of acute myeloid leukemia. Blood, 145(6), 561-566. https://doi.org/10.1182/blood.2024026232
Vancouver
Huls G, Woolthuis CM, Schuringa JJ. Menin inhibitors in the treatment of acute myeloid leukemia. Blood. 2025;145(6):561-566. doi:10.1182/blood.2024026232
BibTeX
@article{Huls2025,
author = {Huls, Gerwin and Woolthuis, Carolien M and Schuringa, Jan Jacob},
title = {Menin inhibitors in the treatment of acute myeloid leukemia},
journal = {Blood},
year = {2025},
volume = {145},
number = {6},
pages = {561--566},
doi = {10.1182/blood.2024026232}
}
EUVIMED